Cargando…
Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
Lanthanum carbonate is an efficacious noncalcium, nonresin phosphate-binder that is being increasingly used in chronic kidney disease stage 5 (CKD-5) dialysis patients. Available evidence has indicated that QT interval changes correlate with mortality in healthy subjects and in dialysis patients. Ex...
Autores principales: | Di Iorio, Biagio, Cucciniello, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262363/ https://www.ncbi.nlm.nih.gov/pubmed/22291491 |
Ejemplares similares
-
QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013) -
Long-term L-Carnitine Administration reduces Erythropoietin Resistance in Chronic Hemodialysis Patients with Thalassemia Minor
por: Di Iorio, Biagio R., et al.
Publicado: (2007) -
The effect of lanthanum carbonate on calciprotein particles in hemodialysis patients
por: Nakamura, Kimihiko, et al.
Publicado: (2019) -
QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory
por: Alabd, Mohamed A., et al.
Publicado: (2011) -
Effects of cinacalcet treatment on QT interval in hemodialysis patients
por: Temiz, Gökhan, et al.
Publicado: (2016)